Asia-Pacific Bladder Cancer Therapeutics and Diagnostics Market Trends

Statistics for the 2023 & 2024 Asia-Pacific Bladder Cancer Therapeutics and Diagnostics market trends, created by Mordor Intelligence™ Industry Reports. Asia-Pacific Bladder Cancer Therapeutics and Diagnostics trend report includes a market forecast to 2029 and historical overview. Get a sample of this industry trends analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Trends of Asia-Pacific Bladder Cancer Therapeutics and Diagnostics Industry

This section covers the major market trends shaping the APAC Bladder Cancer Therapeutics & Diagnostics Market according to our research experts:

Bladder Ultrasound is Expected to Show a Steady Growth During the Forecast Period

Bladder Ultrasound is one of the type of diagnostic device which uses sound waves to detect and analyze the cancer present in the bladder. The growing incidence of bladder cancer and new devices are being developed for the diagnosis of cancer are expected to stimulate the growth in this segment. According to the Globocan, 2018, almost 4,249 incidences of bladder cancer were observed in the Korea Republic of with around 1,712 deaths. Ultrasound is the most common method used in diagnosing the early stages of cancer due to its specificity. Hence, it is expected to boost the demand for ultrasound devices in the market during the forecast period.

APAC BC D&T Market Trends Image.png

Asia-Pacific Bladder Cancer Therapeutics and Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)